Clinical Trial Update: Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating bictegravir/emtricitabine/tenofovir alafenamide in HIV-1–infected, treatment-naïve individuals using a rapid-initiation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Carmen Hidalgo Tenorio | Conditions: HIV Infections | Phase 4 | Status: COMPLETED